Heterogeneous FDG-guided dose-escalation for locally advanced NSCLC (the NARLAL2 trial): Design and early dosimetric results of a randomized, multi-centre phase-III study

Research output: Contribution to journalJournal articleResearchpeer-review


Ditte Sloth Moller, Tine Bjørn Nielsen, Carsten Brink, Lone Hoffmann, Christina Maria Lutz, Mikkel Drogemuller Lund, Olfred Hansen, Tine Schytte, Azza Ahmed Khalil, Marianne Marquard Knap, Christa Haugaard Nyhus, Wiviann Ottosson, Patrik Sibolt, Svetlana Borissova, Mirjana Josipovic, Gitte Persson, Ane Lindegaard Appelt

Original languageEnglish
JournalRadiotherapy & Oncology
Issue number2
Pages (from-to)311-317
Publication statusPublished - Aug 2017

    Research areas

  • NSCLC, Dose-escalation, Randomized phase-III trial

Number of downloads are based on statistics from Google Scholar and www.ku.dk

No data available

ID: 184386819